To investigate whether activation of TGR5 has any effect on the NF-κB pathway in gastric cells, we tested the influence of TGR5 agonists on the NF-κB-mediated gene expression in SGC7901 gastric cancer cells. This evidence concerns the gene GPBAR1 and gastric cancer.